QGEN
NYSE QIAGEN NV$45.63 ↑ +0.32 (+0.71%) Trading Up from the previous close of $45.31
- YTD change
- +1.47%
- vs 20-day SMA
- +3.07%
- vs 200-day SMA
- +7.50%
Price ranges
Price & Performance
+3.40 (+8.11%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 22.7% away from all-time highs of $59.00
- QGEN is up 1% since the beginning of the year
- QGEN is down 3% over the past 12 months
- QGEN is up 9% over the past 1 month
- 4% of all QGEN investors are betting against QGEN
- Number of investors short QGEN has gone up 2% versus last month
QGEN reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is -4.0%.
- Previous minute
- +$0.00
- Last hour
- -$0.22
- Last 5 days
- -0.35%
- vs 8-day SMA
- +1.90%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
